HP&M Director to Present at FDLI Enforcement, Litigation and Compliance ConferenceNovember 7, 2011
The Food and Drug Law Institute’s (“FLDI”) annual Enforcement, Litigation and Compliance Conference is being held in Washington, DC on December 6-7, 2011. Hyman, Phelps & McNamara, P.C. Director John R. Fleder is speaking at the conference. As a result, we were able to secure a discount code for our friends and colleagues. To receive a 15% discount off registration, use the following promotional code: ENFSP2011. To register for the event and to view a copy of the conference brochure, see here.
For nearly 10 years, FDLI’s Enforcement, Litigation and Compliance Conference has been a premier industry event in this field, educating regulatory attorneys and litigators, regulators, compliance experts, consultants and people in academics in enforcement matters relating to the drug, medical device, biologic, diagnostic, food and dietary supplement industries.
Some of the most important developments from the past years will be discussed during this year’s program. Examples include: the government’s crackdown on medical device firms failing to report adverse events, litigation relating to FDA’s import authority, stepped-up enforcement under the False Claims Act, and the latest on investigations and prosecutions related to the Foreign Corrupt Practices Act and potential SEC inquiries. FDA Center Compliance Directors will speak on their priorities and resources for 2012. Attendees will learn how to deal with: visits by government agents to the homes of companies that are under investigation; FDA consent decrees; and other important enforcement-related issues.